|
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Preparing to Give It (Part 1) |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Preparing to Give It (Pt. 1) |
|
Enduring |
|
$0.00 |
|
Turnover Talk: Allied Health Lynch Syndrome |
|
Enduring |
|
$0.00 |
|
Session 3: Barriers to Care |
|
Enduring |
|
$0.00 |
|
Gestational Trophoblastic Neoplasia (GTN) Education Module |
|
Enduring |
|
$15.00 |
|
Turnover Talk: Current Treatment Decisions for Front Line Ovarian Cancer |
|
Enduring |
|
$0.00 |
|
Scientific Plenary IV: Late-breaking Abstracts |
|
Enduring |
|
$0.00 |
|
Focused Plenary III: Biomarkers: Prediction and Prognosis |
|
Enduring |
|
$0.00 |
|
Germline and somatic genetic evaluation in breast and ovarian cancer (Cocktail Part 2): Full Seminar |
|
Enduring |
|
$0.00 |
|
Is Urology in House? Practical Management of Urologic Complications in Common Gyn Oncology Procedures On-Demand Webinar |
|
Enduring |
|
$35.00 |
|
Pathology Lecture Series - Ovarian Germ Cell and Sex Cord-Stromal Tumors |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Tisotumab Vedotin - Preparing to Give It (Part 1) |
|
Enduring |
|
$0.00 |
|
#HashtagThis: Everything You Need to Know About Launching Your Gyn Onc Social Media Research Career On-Demand |
|
Enduring |
|
$0.00 |
|
Evaluation and Management Coding Changes for 2021 |
|
Enduring |
|
$0.00 |
|
All Things Ostomy: An SGO Surgical Education Webinar |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward